Maternal Lipids and Offspring Adiposity at 5-7 Years
HAPO
Maternal Lipids at 28 Weeks Gestation and Offspring Adiposity at Age 5-7 Years in the Hyperglycemia and Adverse Pregnancy Outcome Study
2 other identifiers
observational
1,224
0 countries
N/A
Brief Summary
This study investigates the associations between measured maternal lipids (Total cholesterol, LDL-cholesterol , triglycerides and high-density lipoprotein cholesterol) at 28 weeks' gestation and offspring adiposity at 5-7 years. This was examined in a large observational study based in Belfast, UK.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2001
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 9, 2001
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 4, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
March 14, 2012
CompletedFirst Submitted
Initial submission to the registry
October 10, 2017
CompletedFirst Posted
Study publicly available on registry
October 23, 2017
CompletedOctober 23, 2017
October 1, 2017
5.8 years
October 10, 2017
October 20, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
BMI Z score
Adiposity expressed as body mass index (BMI) Z score
5-7 years
Sum of skin fold thicknesses
Sum of triceps, subscapular and suprailiac
5-7 years
Study Arms (1)
Belfast HAPO
All pregnant women who attended the Royal Victoria Maternity Hospital, Belfast were eligible to participate unless they met one or more exclusion criteria. All eligible women from the Belfast centre were invited to take part in a prospective observational study involving an additional fasting serum sample for lipids at 28 weeks gestation and long term follow up of their HAPO offspring. Only those women who had remained blinded to oral glucose tolerance test (OGTT) results during pregnancy were included (fasting plasma glucose ≤5·8 mmol/L and 2-hour glucose ≤11·1 mmol/L). Offspring from these pregnancies had anthropometric measurements performed within 72 hours of birth and at age 5-7 years.
Eligibility Criteria
All pregnant women who attended the Royal Victoria Maternity Hospital were eligible to participate unless they met one or more of the exclusion criteria.
You may qualify if:
- In a pregnant state in the first/second trimester
- Attending the Royal Victoria Maternity Hospital
You may not qualify if:
- Age younger than 18 years
- A plan to undergo delivery at another hospital
- An uncertain date of last menstrual period and no ultrasonographic estimation between 6 and 24 weeks of gestational age
- Inability to complete the oral glucose-tolerance test within 32 weeks of gestation
- Multiple pregnancy
- Conception by means of gonadotropin ovulation induction or in vitro fertilization
- Glucose testing before recruitment or a diagnosis of diabetes during the current pregnancy
- Diagnosis of diabetes before the current pregnancy and requiring treatment with medication
- Participation in another study that could interfere with the HAPO study
- Infection with the human immunodeficiency virus or hepatitis B or C virus
- Previous participation in the HAPO study
- Inability to converse in the languages used on centre forms without the aid of an interpreter
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
Serum samples remain for a number of participants.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David R McCance, MD
Belfast Health and Social Care Trust
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 10, 2017
First Posted
October 23, 2017
Study Start
January 9, 2001
Primary Completion
November 4, 2006
Study Completion
March 14, 2012
Last Updated
October 23, 2017
Record last verified: 2017-10
Data Sharing
- IPD Sharing
- Will not share